Blar i forfatter "Koldingsnes, Wenche"
-
CHRONIC NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS DOES NOT INCREASE THE RISK OF RELAPSE AND SEVERE INFECTIONS IN GRANULOMATOSIS WITH POLYANGIITIS PATIENTS WHEN RECEIVING RITUXIMAB MAINTENANCE TREATMENT
Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C (Conference object; Konferansebidrag, 2014-06-10) -
Chronic nasal carriage of Staphylococcus aureus in granulomatosis with polyangiitis patients receiving rituximab maintenance: friend or foe?
Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C (Journal article; Tidsskriftartikkel, 2014) -
Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance.
Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C (Conference object; Konferansebidrag, 2013) -
Epidemiology of ANCA associated vasculitis
Nossent, Johannes C; Koldingsnes, Wenche (Journal article; Tidsskriftartikkel; Peer reviewed, 2008) -
Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: results from a single centre.
Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C (Conference object; Konferansebidrag, 2013)Objective: Rituximab (RTX) is an anti-CD20 antibody used successfully in Granulomatosis with Polyangiitis (GPA) for induction and maintenance of remission. Our study aims to evaluate the long term efficacy and safety of chronic pre-emptive RTX therapy in GPA. -
Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: results from a single centre.
Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C (Journal article; Tidsskriftartikkel; Peer reviewed, 2013)Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis with polyangiitis (GPA) for induction and maintenance of remission. Our study aims to evaluate the long-term efficacy and safety of chronic pre-emptive RTX therapy in GPA. Retrospective study of 35 GPA patients treated with RTX between April 2004 and September 2011 for active disease and maintenance. RTX was initiated as ... -
Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis
Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C (Journal article; Tidsskriftartikkel; Peer reviewed, 2014-05-15) -
Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
Besada, Emilio; Koldingsnes, Wenche; Nossent, Hans C (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-06-25)Objective. Chronic nasal carriage of Staphylococcus aureus (SA) increases the risk of relapse while Rituximab (RTX) is an effective agent for inducing and maintaining remission in patients with Granulomatosis with polyangiitis (GPA). We investigated whether B cell depletion and hypogammaglobulinemia that occur during RTX treatment increase the risk of chronic SA nasal carriage and subsequent ... -
Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
Besada, Emilio; Koldingsnes, Wenche; Nossent, Hans (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-06-25)Objective. Chronic nasal carriage of Staphylococcus aureus (SA) increases the risk of relapse while Rituximab (RTX) is an effective agent for inducing and maintaining remission in patients with Granulomatosis with polyangiitis (GPA). We investigated whether B cell depletion and hypogammaglobulinemia that occur during RTX treatment increase the risk of chronic SA nasal carriage and subsequent ...